Key Developments: Becton, Dickinson and Co (BDX)

BDX on New York Consolidated

142.83USD
28 Aug 2015
Change (% chg)

$-0.12 (-0.08%)
Prev Close
$142.95
Open
$142.43
Day's High
$143.11
Day's Low
$141.53
Volume
842,218
Avg. Vol
1,107,203
52-wk High
$154.98
52-wk Low
$112.15

Search Stocks

Latest Key Developments (Source: Significant Developments)

Becton Dickinson and Co declares dividend
Tuesday, 27 Jan 2015 04:05pm EST 

Becton Dickinson and Co:Declares a quarterly dividend of 60 cents per common share.Payable on March 31 to holders of record on March 10.  Full Article

Aethon and BD announce collaboration to develop integrated medication management solution
Friday, 5 Dec 2014 03:42pm EST 

Aethon, Inc. and Becton, Dickinson and Company:Says collaboration to integrate their solutions to provide hospital pharmacies with a comprehensive intravenous medication preparation and delivery tracking solution.With a pilot project already underway, the integrated solution will combine BD's -edge BD Cato IV Workflow product with Aethon's MedEx medication delivery tracking system.  Full Article

Becton Dickinson and Co to offer senior unsecured notes
Thursday, 4 Dec 2014 08:46am EST 

Becton Dickinson and Co:Its intention to offer senior unsecured notes under shelf registration statement on Form S-3.Interest rate, maturity dates and other key terms of offering are to be determined at the time of pricing.Intends to use net proceeds from offering, together with borrowings under its commercial paper program, borrowings under new term loan facility, and cash on hand, to finance acquisition of CareFusion Corporation and to pay related fees and expenses.Says Goldman, Sachs & Co. and J.P. Morgan Securities LLC are acting as joint book-running managers for offering.  Full Article

Becton Dickinson and Co declares dividend
Tuesday, 25 Nov 2014 08:00am EST 

Becton Dickinson and Co:Declares quarterly dividend of $0.60 cents per common share, an increase of about 10.0 pct from previous quarter.Payable on Dec. 31.To holders of record on Dec. 10.The indicated annual dividend rate for fiscal year 2015 is $2.40 per share.  Full Article

Becton Dickinson and Co gives FY 2015 outlook above analysts' estimates
Tuesday, 4 Nov 2014 06:00am EST 

Becton Dickinson and Co:Expect FY 2015 revenues will increase 4.5 to 5.0 pct on a foreign currency-neutral basis.On a reported basis, revenues are expected to increase 2.0 to 2.5 percent due to the unfavorable impact of foreign currency.FY 2015 adjusted diluted earnings per share from continuing operations, excluding amortization of acquisition-related intangibles, to be between $6.76 and $6.83 which represents currency-neutral growth of 8.0 to 9.0 percent over FY 2014 adjusted diluted earnings per share of $6.50.Including the estimated unfavorable impact of foreign-currency, adjusted diluted earnings per share are expected to grow between 4.0 to 5.0 percent.FY 2015 reported diluted earnings per share from continuing operations to be between $6.47 to $6.54.Reported revenues of $8.45 bln in FY 2014.FY 2015 revenues of $8.41 bln and EPS of 6.24 - Thomson Reuters I/B/E/S.  Full Article

Becton Dickinson and Co acquires GenCell Biosystems
Monday, 13 Oct 2014 08:01am EDT 

Becton Dickinson and Co:Says that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols - from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.  Full Article

Becton Dickinson and Co reaffirms FY 2014 guidance
Thursday, 31 Jul 2014 06:00am EDT 

Becton Dickinson and Co:Reaffirms FY 2014 revenue guidance range of 4.5 to 5.0 pct. On a reported.Expects FY 2014 revenue growth of 4.0 to 4.5 pct.Reaffirms FY 2014 diluted earnings per share from continuing operations to be between $6.22 and $6.25.Says foreign currency-neutral basis, adjusted diluted earnings per share growth is expected to be between 10.0 to 10.5 pct, or 11.0 to 11.5 pct excluding the incremental impact of the medical device tax.Reported revenues of $8.1 bln in FY 2013.FY 2014 EPS of $6.25 - Thomson Reuters I/B/E/S.  Full Article

Becton Dickinson and Co declares quarterly dividend
Tuesday, 22 Jul 2014 04:05pm EDT 

Becton Dickinson and Co:Declares quarterly dividend of 54.5 cents per common share.payable on Sept. 30, to holders of record on Sept. 9.  Full Article

Becton Dickinson and Co 's BD Medical signs agreement for installation of BD Cato
Tuesday, 17 Jun 2014 08:30am EDT 

Becton Dickinson and Co:Says BD Medical, segment of company announced an agreement with The University of Texas MD Anderson Cancer Center.For BD Cato, system that enhances safety and workflow efficiency in medication preparation via gravimetric and barcoding technology.MD Anderson Cancer Center will be first healthcare institution in U.S. to implement BD Cato System and will be incorporating the system into its outpatient infusion pharmacies, including community-based locations.  Full Article

Becton Dickinson and Co announces low-volume clinical laboratories now have access to advanced data management with new blood culture instrument connectivity
Wednesday, 11 Jun 2014 09:00am EDT 

Becton Dickinson and Co:Launch of BD BACTEC FX40 Blood Culture System with connectivity to BD EpiCenter Microbiology Data Management System.This communication enables access to advanced reporting capabilities, connectivity to the hospital's Laboratory Information System (LIS) and access to the unique BD Blood Volume Monitoring Software.  Full Article

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters June 9, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events. ** For

Search Stocks